FFA
ABBV icon

Founders Financial Alliance’s AbbVie ABBV Stock Holding History

Founders Financial Alliance’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33M Sell
17,208
-924
-5% -$199K 0.57% 44
2026
Q1 		$3.94M Sell
18,132
-303
-2% -$67.2K 0.71% 33
2025
Q4 		$4.21M Buy
18,435
+90
+0.5% +$20.5K 0.8% 27
2025
Q3 		$4.25M Buy
18,345
+20
+0.1% +$4.07K 0.8% 26
2025
Q2 		$3.4M Buy
18,325
+23
+0.1% +$4.28K 0.77% 26
2025
Q1 		$3.83M Buy
18,302
+272
+2% +$52.9K 0.93% 22
2024
Q4 		$3.2M Sell
18,030
-1,450
-7% -$267K 0.88% 22
2024
Q3 		$3.85M Sell
19,480
-318
-2% -$59.3K 1.07% 18
2024
Q2 		$3.4M Sell
19,798
-39
-0.2% -$6.46K 1.01% 19
2024
Q1 		$3.61M Buy
19,837
+13
+0.1% +$2.24K 1.08% 19
2023
Q4 		$3.07M Buy
19,824
+496
+3% +$72.3K 1.19% 14
2023
Q3 		$2.88M Sell
19,328
-691
-3% -$101K 1.26% 13
2023
Q2 		$2.7M Buy
20,019
+502
+3% +$73.6K 1.06% 17
2023
Q1 		$3.11M Buy
19,517
+153
+0.8% +$23.4K 1.55% 7
2022
Q4 		$3.13M Buy
19,364
+93
+0.5% +$14.3K 1.44% 9
2022
Q3 		$2.59M Buy
19,271
+10,221
+113% +$1.47M 1.32% 8
2022
Q2 		$1.39M Sell
9,050
-8,751
-49% -$1.34M 0.7% 33
2022
Q1 		$2.89M Sell
17,801
-1,158
-6% -$168K 1.28% 11
2021
Q4 		$2.57M Buy
18,959
+2,148
+13% +$254K 1.03% 13
2021
Q3 		$1.81M Buy
16,811
+132
+0.8% +$15.1K 0.85% 23
2021
Q2 		$1.88M Buy
16,679
+256
+2% +$28.8K 0.85% 20
2021
Q1 		$1.84M Buy
16,423
+1,483
+10% +$159K 0.91% 20
2020
Q4 		$1.6M Buy
14,940
+2,837
+23% +$273K 0.91% 24
2020
Q3 		$1.06M Buy
+12,103
New +$1.14M 0.63% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Founders Financial Alliance's ABBV Position: Q2 2026 in Review

Founders Financial Alliance reduced its AbbVie (ABBV) stake by 5.1% in Q2 2026, selling an estimated $199K and leaving 17,208 shares worth $4.33M. The position accounts for 0.57% of the portfolio, ranked #44.

Founders Financial Alliance first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Founders Financial Alliance held 17,208 shares of AbbVie worth $4.33M as of Q2 2026.
  • Founders Financial Alliance sold 924 AbbVie shares in Q2 2026, an estimated $199K.
  • AbbVie made up 0.57% of Founders Financial Alliance's portfolio in Q2 2026, its #44 holding.
  • Founders Financial Alliance first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.